Study finds that MRI is more sensitive than PSA test for detecting prostate cancer

The recent BMJ Oncology study finds that using MRI screenings based on age can effectively identify prostate cancer risks independent of traditional PSA levels. The findings suggest that an MRI-based approach could be a more accurate alternative for prostate cancer screening, particularly for men with PSA levels lower than 3.0 ng/mL.